Xylitol: Clinical Trials

46 trials of Xylitol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

27 completed, 6 unknown, 4 withdrawn, 3 recruiting. 20 Not applicable, 17 Phase 2, 8 Phase 3, 6 Phase 1, 4 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable20Completed 12, Unknown 4, Recruiting 2, Active not recruiting 1, Withdrawn 1
Phase 217Completed 10, Terminated 3, Withdrawn 2, Recruiting 1, Unknown 1
Phase 38Completed 6, Unknown 1, Withdrawn 1
Phase 16Completed 4, Not yet recruiting 1, Recruiting 1
Phase 44Completed 3, Unknown 1
Early Phase 11Not yet recruiting 1

Follow Xylitol: new trials by email Literature Review of Xylitol trials Research Report on Xylitol

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot Trial of Xylitol for C. Difficile De-Colonization in Patients With Inflammatory Bowel Disease
Xylitol - Inflammatory Bowel Disease (IBD), Clostridioides Difficile Infection
Early Phase 1Not yet recruitingBrigham and Women's Hospital692026-09-012025-12-16
Xylitol Use for Decolonization of C. Difficile in Patients With IBD
Xylitol, Placebo - Inflammatory Bowel Diseases, Clostridioides Difficile Infection
Phase 1Not yet recruitingBrigham and Women's Hospital992026-08-012026-02-25
Effect of Enzymatic-Containing Mouth Spray (Oral7®) on Xerostomia Symptoms, Salivary Flow Rate, and Oral Health-Related Quality of Life in Older Patients
Oral7® mouth spray contains Natural Enzymes (Lactoperoxidase, Glucose Oxidase, Lactoferrin, Lysozyme), Calcium, Xylitol, Aloe Vera, Natural peppermint. - Xerostomia, Geriatric
Not applicableRecruitingZAINAB MAT YUDIN1002025-09-182026-05-22
Peritoneal Ultrafiltration in Cardio Renal Syndrome.
PolyCore (Polydextrin, L-Carnitine, D-xylitol) - Congestive Heart Failure
Phase 1 / Phase 2RecruitingIperboreal Pharma Srl842025-04-162025-05-16
Effects of Caffeine and Nicotine Gum on Balance Performance in Athletes
Caffeine Gum 3mg/kg, Nicotine Gum (4 mg), Placebo Gum (Xylitol) - Athletic Performance, Postural Stability
Not applicableCompletedGülbin Rudarlı202024-01-082025-12-04
Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant
Xylitol, Placebo - Allogeneic Stem Cell Transplantation
Phase 2TerminatedChildren's Hospital Medical Center, Cincinnati2562023-04-042026-09-28
Effects of Oral Xylitol on Subsequent Energy Intake
Xylitol, Sucrose, Acesulfame Potassium - Energy Intake, Gastrointestinal Hormones
Not applicableCompletedUniversity Hospital, Basel, Switzerland212023-01-272024-08-19
Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients and Quality of Life Assessed by PROMs.
XCM-OM118 Composition comprising olive oil, betaine and xylitol - Oral Mucositis, Quality of Life
Not applicableRecruitingMucosa Innovations, S.L.632022-10-112026-04-15
Effect on Cytokines IL-1ß, TNF-α, IL-4, and Total Bacterial Load of a Composition Comprising Olive Oil, Trimethylglycine and Xylitol Delivered as a Toothpaste
Toothpaste with olive oil, trimethylglycine and xylitol, Toothpaste without olive oil, trimethylglycine nor xylitol - Inflammation, Interleukin-1beta
Not applicableCompletedMucosa Innovations, S.L.262022-06-132025-03-10
Impact of GSE and Xylitol (Xlear) on COVID-19 Symptoms and Time to PCR Negativisation in COVID-19 Patients
GSE and Xylitol, Control Placebo - Covid19
Phase 3WithdrawnLarkin Community Hospital2021-12-162023-10-16
Effect of Daily Erythritol Versus Sucrose Intake Over 5 Weeks on Glucose Tolerance in Adolescents
Erythritol, Sucrose, Glucose - Insulin Resistance, Glucose Tolerance
Not applicableActive not recruitingUniversity Hospital, Basel, Switzerland302021-08-182026-09-30
Effect of the Use of Xylitol Gum in the Prevention of Caries Lesions in Children Living in Ladakh
Administration of sugar-free gums sugar-free gums containing 100% Xylitol as sweetener, Administration of sugar-free gums sugar-free gums containing containing a polyols mixture plus a low amount of Xylitol (22%) - Caries
Not applicableWithdrawnUniversity of Bern2021-08-012025-09-26
Effects of a Composition on the Oral Microbiome, pH, Nitrite/Nitrate Ratio, Elastases and Inflammation in Oral Dysbiosis
Test composition Saliactive® (olive product, betaine and xylitol), Placebo, Control - Oral Dysbiosis
Phase 2 / Phase 3CompletedMucosa Innovations, S.L.1002021-07-132024-07-08
Consumption of Oral Artificial Sweeteners on Platelet Aggregation and Polyol Excretion
xylitol, 30g, erythritol, 30g, xylitol, 5g - Cardiovascular Risk Factor
Not applicableCompletedThe Cleveland Clinic502021-03-102026-07-13
Blinded Dry Mouth Spray Crossover Study
Remineralizing Extreme Dry Mouth Spray with Xylitol, Alcohol-Free Moisturizing Dry Mouth Spray - Xerostomia, Head and Neck Cancer
Not applicableCompletedJonas Johnson1292021-01-142024-02-01
A Novel Approach in Reducing Dental Pain and Anxiety of Pediatric Patient During Local Anesthesia.
Lidocaine Hydrochloride, Virtual reality device (Harga Miniso Vr Glass 3d terbaru), Xylitol - Anxiety, Pain
Not applicableCompletedRiyadh Elm University312020-11-012021-11-11
Vitamin D in School Children
Oral vitamin D spray, Placebo - Vitamin D Deficiency, Musculoskeletal Diseases
Not applicableUnknownUniversity of Ulster1182019-11-012021-08-24
Ultrafiltration Efficacy of a PD Solution Containing Icodextrin-Xylitol-Carnitine
Icodextrin, xylitol and carnitine solution for peritoneal dialysis, EXTRANEAL 7.5G/100Ml Peritoneal Dialysis Solution - End Stage Renal Disease (ESRD)
Phase 2WithdrawnIperboreal Pharma Srl2019-10-022024-10-01
Xylitol - Healthcare Associated Infection Reduction in Stem Cell Transplant Patients
Xylitol, Placebo - Allogeneic Hematopoietic Cell Transplantation
Phase 2TerminatedChildren's Hospital Medical Center, Cincinnati462019-09-272023-02-08
Efficacy and Safety Assessments of a Peritoneal Dialysis Solution Containing Glucose, Xylitol, and L-Carnitine in CAPD
1.5% Xylitol, 0.5% Glucose, and 0.02% L-carnitine, 0.7% Xylitol, 0.5% Glucose, and 0.02% L-carnitine - End Stage Renal Disease
Phase 2TerminatedIperboreal Pharma Srl112019-09-012023-03-03

Showing 20 of 46. Sign in to see all of them.

Conditions studied

Dental Caries (6)  ·  Xerostomia (4)  ·  Gingivitis (3)  ·  Mucositis (3)  ·  Clostridium Infections (2)  ·  Cystic Fibrosis (2)  ·  Dental Plaque (2)  ·  Endocrine System Diseases (2)  ·  Head and Neck Neoplasms (2)  ·  Inflammatory Bowel Diseases (2)  ·  Kidney Failure, Chronic (2)  ·  Pain (2)  ·  Plaque, Amyloid (2)  ·  Sinusitis (2)  ·  Stomatitis (2)

Sponsors

University Hospital, Basel, Switzerland (6)  ·  Iperboreal Pharma Srl (3)  ·  Mucosa Innovations, S.L. (3)  ·  Brigham and Women's Hospital (2)  ·  Children's Hospital Medical Center, Cincinnati (2)  ·  Joseph Zabner (2)  ·  Augusta University (1)  ·  Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (1)  ·  Cairo University (1)  ·  Dr. Krupa NC (1)  ·  Finnish Institute for Health and Welfare (1)  ·  Gülbin Rudarlı (1)  ·  Hadassah Medical Organization (1)  ·  Jonas Johnson (1)  ·  King Abdulaziz University (1)

Countries

United States (16)  ·  Switzerland (6)  ·  Italy (3)  ·  Spain (3)  ·  Finland (2)  ·  Russia (2)  ·  Saudi Arabia (2)  ·  Brazil (1)  ·  China (1)  ·  Colombia (1)  ·  Egypt (1)  ·  Estonia (1)  ·  India (1)  ·  Israel (1)  ·  Kuwait (1)

Top investigators

Christoph Beglinger, Prof. (2)  ·  Eino Honkala, PhD (2)  ·  Lakshmi Durairaj, M.D. (2)  ·  Mario Bonomini, MD (2)  ·  AbdulRahman Alasmari, Resident (1)  ·  Alison J Lunsford, MD (1)  ·  Anne Christin Meyer-Gerspach (1)  ·  Christoph Beglinger, MD (1)  ·  Christoph Beglinger, Prof (1)  ·  Christopher Dandoy, MD, MSc (1)  ·  Deyu Hu, Ph.D. (1)  ·  Domenico Dalessandri, Prof. (1)

Results publications

PMID 18973181, PMID 10901408, PMID 11499519, PMID 11853248, PMID 12000350, PMID 15023840, PMID 15162342, PMID 15316237, PMID 15510034, PMID 16490089, PMID 16996689, PMID 17405780, PMID 17882910, PMID 19152564, PMID 20920261, PMID 21109081, PMID 21236454, PMID 21994147, PMID 22607272, PMID 23283923, PMID 23378777, PMID 23534323, PMID 23571819, PMID 23589387, PMID 23785241, PMID 24095985, PMID 24205951, PMID 24852946, PMID 25240992, PMID 27394715, PMID 27806364, PMID 27875537, PMID 28390807, PMID 28779942, PMID 29498793, PMID 30999906, PMID 31327670, PMID 31669738, PMID 32671834, PMID 34674574, PMID 34863260, PMID 35968060, PMID 36472884, PMID 36849732, PMID 38842092, PMID 39114916, PMID 39940340, PMID 41887286, PMID 41981946, PMID 8281565

NIH funding

1UG3DE030401-01 (1), R21CA158530 (1), U01DE018038 (1)